Advertisement
J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1194/jlr.M200273-JLR200 on March 1, 2003

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M200273-JLR200v1
44/5/884    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krimbou, L.
Right arrow Articles by Genest, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krimbou, L.
Right arrow Articles by Genest, J., Jr.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol. 44, 884-892, May 2003
Copyright © 2003 by Lipid Research, Inc.

Structural and functional properties of human plasma high density-sized lipoprotein containing only apoE particles

Larbi Krimbou*, Michel Marcil*, Hitoshi Chiba{dagger} and Jacques Genest, Jr.1,*

* Cardiovascular Genetics Laboratory, McGill University Health Center/Royal Victoria Hospital, Montréal, Québec H3A 1A1, Canada
{dagger} Department of Laboratory Medicine, Hokkaido University School of Medicine, North-14, West-5, Sapporo 060-8648, Japan

1 To whom correspondence should be addressed. e-mail: jacques.genest{at}muhc.mcgill.ca

To investigate the metabolism of HDL-apolipoprotein E (apoE) particles in human plasma, we isolated a fraction of plasma HDL-apoEs that lack apoA-I (HDL-LpE) from subjects with apoE3/3 phenotype by immunoaffinity. Plasma HDL-LpE had a particle size ranging from 9 nm to 18.5 nm in diameter and was characterized by two-dimensional nondenaturing gradient gel electrophoresis as having either {gamma}-, preß1-, preß2-, or {alpha}-electrophoretic mobility. HDL-LpE was also present in the medium of cultured human hepatoma cell lines and monocyte-derived macrophages. The majority of apoE3 was found as a monomeric form in HDL-LpE and floated at density d > 1.21 g/ml. Plasma levels of HDL-LpE in normolipidemic, CETP-deficient, and ABCA1-deficient subjects were 0.72 ± 0.15 mg/dl (n = 12), 1.77 ± 0.75 mg/dl (n = 3), and 0.55 ± 0.11 mg/dl (n = 3), respectively. The ratio of HDL-apoE containing apoA-I to HDL-LpE was significantly higher 4 h after a fat load, representing a 35 ± 9% increase (n = 3). Isolated plasma HDL-LpE3 was as effective as apoE3, reconstituted HDL particles, or apoA-I in promoting cellular cholesterol efflux.

These results demonstrate that 1) plasma HDL-LpE may have hepatogenous and macrophagic origins; 2) HDL-LpE was preserved even with large reductions in apoA-I-containing lipoproteins; 3) HDL-LpE was active in the transfer of apoE to triglyceride-rich lipoproteins, and 4) HDL-LpEs efficiently take up cell-derived cholesterol.

Abbreviations: ABCA1, ATP binding cassette A1; CE, cholesteryl ester; CETP, cholesteryl ester transfer protein; LpE, lipoprotein containing only apoE; PEG, polyethylene glycol; RCT, reverse cholesterol transport; TD, Tangier disease; TRL, triglyceride-rich lipoprotein; 2D-PAGGE, two-dimensional nondenaturing gradient gel electrophoresis

Supplementary key words HDL-apoE • hypoalphalipoproteinemia • postprandial lipemia • cholesterol efflux • reverse cholesterol transport


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G. Catalano, Z. Julia, E. Frisdal, B. Vedie, N. Fournier, W. Le Goff, M. J. Chapman, and M. Guerin
Torcetrapib Differentially Modulates the Biological Activities of HDL2 and HDL3 Particles in the Reverse Cholesterol Transport Pathway
Arterioscler. Thromb. Vasc. Biol., February 1, 2009; 29(2): 268 - 275.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
N. Settasatian, P. J. Barter, and K.-A. Rye
Remodeling of apolipoprotein E-containing spherical reconstituted high density lipoproteins by phospholipid transfer protein
J. Lipid Res., January 1, 2008; 49(1): 115 - 126.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Guerin, W. Le Goff, E. Duchene, Z. Julia, T. Nguyen, T. Thuren, C. L. Shear, and M. J. Chapman
Inhibition of CETP by Torcetrapib Attenuates the Atherogenicity of Postprandial TG-Rich Lipoproteins in Type IIB Hyperlipidemia
Arterioscler. Thromb. Vasc. Biol., January 1, 2008; 28(1): 148 - 154.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. G. Yancey, H. Yu, M. F. Linton, and S. Fazio
A Pathway-Dependent on ApoE, ApoAI, and ABCA1 Determines Formation of Buoyant High-Density Lipoprotein by Macrophage Foam Cells
Arterioscler. Thromb. Vasc. Biol., May 1, 2007; 27(5): 1123 - 1131.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
K.-A. Rye, R. Bright, M. Psaltis, and P. J. Barter
Regulation of reconstituted high density lipoprotein structure and remodeling by apolipoprotein E
J. Lipid Res., May 1, 2006; 47(5): 1025 - 1036.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
L. Krimbou, H. Hajj Hassan, S. Blain, S. Rashid, M. Denis, M. Marcil, and J. Genest
Biogenesis and speciation of nascent apoA-I-containing particles in various cell lines
J. Lipid Res., August 1, 2005; 46(8): 1668 - 1677.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
H. Hajj Hassan, S. Blain, B. Boucher, M. Denis, L. Krimbou, and J. Genest
Structural modification of plasma HDL by phospholipids promotes efficient ABCA1-mediated cholesterol release
J. Lipid Res., July 1, 2005; 46(7): 1457 - 1465.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. L. Raffai, S. M. Loeb, and K. H. Weisgraber
Apolipoprotein E Promotes the Regression of Atherosclerosis Independently of Lowering Plasma Cholesterol Levels
Arterioscler. Thromb. Vasc. Biol., February 1, 2005; 25(2): 436 - 441.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
L. Krimbou, M. Denis, B. Haidar, M. Carrier, M. Marcil, and J. Genest Jr.
Molecular interactions between apoE and ABCA1: impact on apoE lipidation
J. Lipid Res., May 1, 2004; 45(5): 839 - 848.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Haidar, M. Denis, M. Marcil, L. Krimbou, and J. Genest Jr.
Apolipoprotein A-I Activates Cellular cAMP Signaling through the ABCA1 Transporter
J. Biol. Chem., March 12, 2004; 279(11): 9963 - 9969.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Denis, B. Haidar, M. Marcil, M. Bouvier, L. Krimbou, and J. Genest Jr.
Molecular and Cellular Physiology of Apolipoprotein A-I Lipidation by the ATP-binding Cassette Transporter A1 (ABCA1)
J. Biol. Chem., February 27, 2004; 279(9): 7384 - 7394.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement